Antimalarial Research in the AmazonMany patients who receive treatment for vivax malaria in the Americas present with recurrent infection within six months after completing treatment. This raises an important question: Does higher-dose primaquine work better than the treatment currently used in the Americas to prevent recurrences? This Clinical Trial Case Study describes the behind-the-scenes story of a randomized trial to evaluate antimalarial treatment efficacy in the Brazilian Amazon.